Evid Invest
Who owns RLAYWhat RLAY owns — n/a

Who owns Relay Therapeutics, Inc.?

Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.

Institutional ownership of RLAY from SEC Form 13F filings across 262 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.

As of the 2026-09-30 reporting period, 262 institutions disclosed 253.0M shares of Relay Therapeutics, Inc. worth $4.57B — about 115.5% of shares outstanding; the largest disclosed holder is FMR LLC. Source: SEC Form 13F filings, parsed by EvidInvest.

262

13F holders

$4.57B

value, 2026 filers

115.5%

of shares outstanding (253.0M sh)

35

new positions (2026 filers)

Top institutional holders

ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of RLAY's shares outstanding

#ManagerSharesValue% of fund% of co.Δ shares QoQ
1FMR LLC24.2M$437.5M0.0%11.1%+20.5%
2SB INVESTMENT ADVISERS (UK) LTD21.9M$395.4M6.4%10%-21.5%
3T. Rowe Price Investment Management, Inc.17.9M$322.5M0.2%8.2%+832.8%
4BlackRock, Inc.16.7M$301.4M0.0%7.6%+9.2%
5Casdin Capital, LLC16.0M$289.4M12.6%7.3%0.0%
6PERCEPTIVE ADVISORS LLC12.7M$229.8M4.0%5.8%-9.8%
7Commodore Capital LP12.0M$216.6M16.8%5.5%0.0%
8STATE STREET CORP9.2M$165.2M0.0%4.2%-9.6%
9VANGUARD CAPITAL MANAGEMENT LLC9.0M$162.7M0.0%4.1%+0.5%
10Nextech Invest Ltd.6.8M$122.3M5.5%3.1%0.0%
11PRICE T ROWE ASSOCIATES INC /MD/6.6M$119.7M0.0%3%-14.0%
12Bellevue Group AG6.2M$111.7M2.3%2.8%0.0%
13GEODE CAPITAL MANAGEMENT, LLC5.1M$92.1M0.0%2.3%+8.0%
14ALLIANCEBERNSTEIN L.P.3.9M$70.7M0.0%1.8%-4.3%
15TCG Crossover Management, LLC3.8M$68.3M1.9%1.7%-11.5%
16WESTFIELD CAPITAL MANAGEMENT CO LP3.6M$65.2M0.2%1.6%+8.1%
17Siren, L.L.C.3.3M$58.9M1.4%1.5%-10.6%
18DIMENSIONAL FUND ADVISORS LP3.2M$57.3M0.0%1.4%+1.6%
19BANK OF AMERICA CORP /DE/3.1M$56.0M0.0%1.4%+15.1%
20Spruce Street Capital LP3.0M$53.9M8.6%1.4%0.0%
21BAKER BROS. ADVISORS LP2.8M$51.0M0.2%1.3%0.0%
22Kynam Capital Management, LP2.8M$49.7M2.7%1.3%-16.6%
23MORGAN STANLEY2.6M$46.8M0.0%1.2%-32.7%
24MPM BIOIMPACT LLC2.4M$42.8M3.2%1.1%-1.9%
25VANGUARD PORTFOLIO MANAGEMENT LLC2.3M$41.9M0.0%1.1%-19.7%

Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.

EvidInvest is an independent research and information tool. Figures are calculated from public SEC filings and third-party market data and are provided for informational and educational purposes only. EvidInvest does not provide investment advice, brokerage, or financial services, and is not affiliated with any company it covers. Verify all figures against primary sources before making any decision.